{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:46:55Z","timestamp":1768704415504,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ijrobp.2022.07.017","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T11:48:16Z","timestamp":1658490496000},"page":"501-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Systematic Comparison of Dose Distributions Delivered in 125I Plaque Brachytherapy and Proton Radiation Therapy for Ocular Melanoma"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-9699","authenticated-orcid":false,"given":"Alexei V.","family":"Trofimov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos S.","family":"Gragoudas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence K.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandar S.","family":"Bhagwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.07.017_bib0001","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0161-6420(80)35194-4","article-title":"Radiotherapy of choroidal melanoma with iodine-125","volume":"87","author":"Packer","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"American Brachytherapy Society Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0003","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archopht.1982.01030030936007","article-title":"Proton beam irradiation of uveal melanomas. Results of 5 1\/2-year study","volume":"100","author":"Gragoudas","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0004","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archopht.1986.01050150102037","article-title":"Ciliochoroidal melanomas treated with a narrow medical proton beam","volume":"104","author":"Brovkina","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0360-3016(99)00147-9","article-title":"Results of proton therapy of uveal melanomas treated in Nice","volume":"45","author":"Courdi","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0006","series-title":"COMS Manual of Procedures","article-title":"Chapter 12: Radiation therapy","year":"1995"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0007","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0008","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: Report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0009","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1259\/bjr\/76813976","article-title":"Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (\u22645 mm) choroidal melanoma lesions","volume":"81","author":"Wilkinson","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0011","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.brachy.2019.01.005","article-title":"Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma","volume":"18","author":"Dean","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0012","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjophthalmol-2020-318063","article-title":"Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field)","volume":"106","author":"Oxenreiter","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0013","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2016.02.039","article-title":"Feasibility of proton beam therapy for ocular melanoma using a novel 3D treatment planning technique","volume":"95","author":"Hartsell","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.599018","article-title":"Clinical implementation of proton therapy using pencil-beam scanning delivery combined with static apertures","volume":"11","author":"B\u00e4umer","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijrobp.2019.02.005","article-title":"Corneal substructure dosimetry predicts corneal toxicity in patients with uveal melanoma treated with proton beam therapy","volume":"104","author":"Lee","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0016","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2016.01.040","article-title":"Practice patterns analysis of ocular proton therapy centers: The international OPTIC survey","volume":"95","author":"Hrbacek","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-009-9811-x","article-title":"Initial results of fractionated CyberKnife radiosurgery for uveal melanoma","volume":"94","author":"Zorlu","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0018","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2013.08.004","article-title":"Hypofractionated stereotactic photon radiotherapy of posteriorly located choroidal melanoma with five fractions at ten Gy\u2014clinical results after six years of experience","volume":"108","author":"Dunavoelgyi","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0019","series-title":"Cancer Incidence in Five Continents, Vol VII","author":"Parkin","year":"1997"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0021","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the U. S","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0022","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/ICU.0000000000000468","article-title":"Plaque brachytherapy for posterior uveal melanoma in 2018: Improved techniques and expanded indications","volume":"29","author":"Reichstein","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0023","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0161-6420(99)90456-6","article-title":"Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma","volume":"106","author":"Wilson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0024","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2015.01.029","article-title":"Long-term results of the UCSF-LBNL randomized trial: Charged particle with helium ion versus iodine-125 plaque therapy for choroidal and ciliary body melanoma","volume":"92","author":"Mishra","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mayocpiqo.2021.10.002","article-title":"Treatment of uveal melanoma with radioactive iodine 125 implant compared with proton beam radiotherapy","volume":"6","author":"Bolling","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0026","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/rpd\/nci266","article-title":"106Ru\/106Rh plaque and proton radiotherapy for ocular melanoma: A comparative dosimetric study","volume":"116","author":"Mourtada","year":"2005","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0027","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ijrobp.2004.09.062","article-title":"Improved treatment planning for COMS eye plaques","volume":"61","author":"Astrahan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0028","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1118\/1.595258","article-title":"Planning proton therapy of the eye","volume":"10","author":"Goitein","year":"1983","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0029","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ajo.2009.11.006","article-title":"Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma","volume":"149","author":"Finger","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0030","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archopht.120.12.1665","article-title":"Evidence-based estimates of outcome in patients irradiated for intraocular melanoma","volume":"120","author":"Gragoudas","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0031","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","article-title":"Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: A detailed analysis of tumor and dose-volume parameters","volume":"87","author":"Mishra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0032","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2010.02.051","article-title":"Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy","volume":"80","author":"Finger","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0033","article-title":"Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease","volume":"41","author":"Slopsema","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0034","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1002\/mp.15024","article-title":"Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison","volume":"48","author":"Fleury","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0035","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/mp.15573","article-title":"Technical note: Impact of beam properties for uveal melanoma proton therapy - An in silico planning study","volume":"49","author":"Wulff","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0036","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0037","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0038","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2006.01.020","article-title":"Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay proton therapy center (ICPO)","volume":"65","author":"Dendale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.017_bib0039","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00417-018-4036-3","article-title":"Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma","volume":"256","author":"Busch","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622007398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622007398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:04:36Z","timestamp":1759745076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622007398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0360301622007398"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.017","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Comparison of Dose Distributions Delivered in 125I Plaque Brachytherapy and Proton Radiation Therapy for Ocular Melanoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}